Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.19.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Income Statement [Abstract]    
Product revenue $ 97
Costs of revenue 79
Gross profit 18
Operating expenses:    
Research and development 718 877
General and administrative 971 1,307
Sales and marketing 59 47
Total operating expenses 1,748 2,231
Loss from operations (1,730) (2,231)
Other income (expenses):    
Interest income 122
Interest expense (476)
Loss on extinguishment of debt (340)
Change in fair value of derivative liabilities (21) 811
Loss on extinguishment of derivative liabilities (1,252)
Other income, net 2
Total other income (expense), net 101 (1,255)
Net loss before income taxes (1,629) (3,486)
Provision for income taxes
Loss from continuing operations (1,629) (3,486)
Income from discontinued operations 87
Net loss (1,629) (3,399)
Deemed dividend related to beneficial conversion feature and accretion of discount on convertible Series A preferred stock (9)
Net loss attributable to common stockholders $ (1,629) $ (3,408)
Net earnings (loss) per share - basic and diluted    
Basic - continuing operations $ (0.07) $ (1.02)
Basic - discontinued operations 0.02
Basic - attributable to common stockholders (0.07) (1.00)
Diluted - continuing operations (1.11)
Diluted - discontinued operations 0.02
Diluted - attributable to common stockholders $ (1.09)
Weighted average common shares outstanding:    
Basic 21,793,641 3,411,246
Diluted 21,793,641 3,411,246